Valuation: Electromed, Inc.

Market Cap 221M 197M 183M 165M 309M 20.99B 314M 2.2B 869M 10.98B 828M 810M 34.76B P/E 2027 *
18.3x
P/E 2028 * 15.8x
Enterprise Value 221M 197M 183M 165M 309M 20.99B 314M 2.2B 869M 10.98B 828M 810M 34.76B EV / Sales 2027 *
2.65x
EV / Sales 2028 * 2.4x
Free-Float
82.79%
Yield 2027 *
-
Yield 2028 * -
1 day+0.95%
1 week-2.85%
Current month-5.70%
1 month-4.52%
3 months-30.70%
6 months+0.87%
Current year-8.59%
1 week 26.24
Extreme 26.24
27.8
1 month 26.24
Extreme 26.24
28.95
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 2023-06-30
Director of Finance/CFO 44 2022-11-13
Compliance Officer - 2023-08-31
Director TitleAgeSince
Chairman 70 2023-06-30
Director/Board Member 76 2014-11-20
Director/Board Member 57 2019-08-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Chief Financial Officer

15,602 0.1865%
9/1/26 Tax

Chief Executive Officer

-2,671 0.0319%
6/30/26 Tax

Chief Financial Officer

-674 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%-2.85%+9.68%+158.45% 219M
+1.64%+0.81%+19.63%+55.60% 249B
+1.07%+3.81%+4.47%+20.29% 162B
-0.15%+4.26%-17.36%+74.03% 157B
-0.24%+1.18%-54.92%-8.44% 66.22B
-1.50%+0.44%+8.59%+67.34% 52.3B
+1.03%+3.07%-14.62%-8.28% 52.18B
+1.67%+3.83%+19.00%+44.25% 51.34B
+1.67%+3.57%+18.87%+68.69% 48.79B
+0.51%+5.00%+26.84%+86.53% 44.57B
Average +0.67%+2.21%+2.02%+55.85% 88.37B
Weighted average by Cap. +0.80%+2.65%+2.31%+46.16%

Financials

2027 *2028 *
Net sales 83.15M 74.35M 68.79M 62.28M 117M 7.91B 118M 828M 327M 4.14B 312M 305M 13.1B 92.05M 82.31M 76.15M 68.95M 129M 8.76B 131M 916M 362M 4.58B 345M 338M 14.5B
Net income 12.6M 11.27M 10.42M 9.44M 17.66M 1.2B 17.95M 125M 49.62M 627M 47.29M 46.28M 1.99B 14.75M 13.19M 12.2M 11.05M 20.68M 1.4B 21.02M 147M 58.08M 734M 55.36M 54.18M 2.32B
Net Debt - -
Projected Income Statement - Annual - Electromed, Inc.
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
26-10-26 US$26.62 +0.95% 42,479
26-10-23 US$26.37 -1.86% 40,376
26-10-22 US$26.87 -1.65% 32,706
26-10-21 US$27.32 -0.44% 35,785
26-10-20 US$27.44 +0.15% 38,291
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Electromed, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.62USD
Average target price
48.50USD
Spread / Average Target
+82.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Electromed, Inc.
  1. Stock Market
  2. Stocks
  3. ELMD Stock